Treatments for HBV: A Glimpse into the Future

The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartoli, Alessandra, Gabrielli, Filippo, Tassi, Andrea, Cursaro, Carmela, Pinelli, Ambra, Andreone, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473442/
https://www.ncbi.nlm.nih.gov/pubmed/34578347
http://dx.doi.org/10.3390/v13091767
_version_ 1784574993324048384
author Bartoli, Alessandra
Gabrielli, Filippo
Tassi, Andrea
Cursaro, Carmela
Pinelli, Ambra
Andreone, Pietro
author_facet Bartoli, Alessandra
Gabrielli, Filippo
Tassi, Andrea
Cursaro, Carmela
Pinelli, Ambra
Andreone, Pietro
author_sort Bartoli, Alessandra
collection PubMed
description The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.
format Online
Article
Text
id pubmed-8473442
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84734422021-09-28 Treatments for HBV: A Glimpse into the Future Bartoli, Alessandra Gabrielli, Filippo Tassi, Andrea Cursaro, Carmela Pinelli, Ambra Andreone, Pietro Viruses Review The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV. MDPI 2021-09-04 /pmc/articles/PMC8473442/ /pubmed/34578347 http://dx.doi.org/10.3390/v13091767 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bartoli, Alessandra
Gabrielli, Filippo
Tassi, Andrea
Cursaro, Carmela
Pinelli, Ambra
Andreone, Pietro
Treatments for HBV: A Glimpse into the Future
title Treatments for HBV: A Glimpse into the Future
title_full Treatments for HBV: A Glimpse into the Future
title_fullStr Treatments for HBV: A Glimpse into the Future
title_full_unstemmed Treatments for HBV: A Glimpse into the Future
title_short Treatments for HBV: A Glimpse into the Future
title_sort treatments for hbv: a glimpse into the future
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473442/
https://www.ncbi.nlm.nih.gov/pubmed/34578347
http://dx.doi.org/10.3390/v13091767
work_keys_str_mv AT bartolialessandra treatmentsforhbvaglimpseintothefuture
AT gabriellifilippo treatmentsforhbvaglimpseintothefuture
AT tassiandrea treatmentsforhbvaglimpseintothefuture
AT cursarocarmela treatmentsforhbvaglimpseintothefuture
AT pinelliambra treatmentsforhbvaglimpseintothefuture
AT andreonepietro treatmentsforhbvaglimpseintothefuture

Ejemplares similares